ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 12

Use of Ultrasound to Determine Remission Status in Children with Juvenile Idiopathic Arthritis

Ottar Kristinsson1, Lisabeth Scalzi2, Michael Bruno2, Cristy French2, Vernon Chinchilli2 and Brandt Groh2, 1Pediatrics, Penn State Hershey Medical Center, Hershey, PA, 2Penn State Hershey Medical Center, Hershey, PA

Meeting: 2017 Pediatric Rheumatology Symposium

Keywords: juvenile idiopathic arthritis (JIA), remission and ultrasonography

  • Tweet
  • Email
  • Print
Session Information

Date: Thursday, May 18, 2017

Title: Clinical and Therapeutic Poster Breakout I

Session Type: Abstract Submissions

Session Time: 4:45PM-5:15PM

Background/Purpose: The ultimate goal for clinicians caring for children with Juvenile idiopathic arthritis (JIA) is to attain disease remission off medications. Correct identification of remission is crucial in the decision to withdraw medications. Ultrasound (US) is a non-invasive and sensitive technique used to detect the presence of active synovitis. Between 30-40% of JIA patients in physician diagnosed clinical remission demonstrated persistent active synovitis with ultrasound in published experiences, and withdrawal of medications in these patients may precipitate a disease relapse. The purpose of this study is to assess whether or not the use of ultrasound can better enable pediatric rheumatologists to determine clinical remission in children with JIA.

Methods: We recruited 41children with either oligoarticular or polyarticular JIA, 17 with clinically active disease and 24 in clinical remission. Three to 6 joints were scanned using US in each child, including the currently or previously most active joints. Joint effusion, synovial thickening, erosions and synovial hyperemia by Power Doppler signal were recorded within each joint. These four variables were scored on a scale from 0-3 and a score of 2 or 3 was considered to represent significant clinical change. Univariate and multivariate logistic regression analyses were performed, to best distinguish the two groups. Inter-reader reliability was calculated using Cohen’s kappa statistics between two independent ultrasonographers.

Results: Of the 41 subjects, 73.2% were female, 90.3% were Caucasian and 48.8% were polyarticular. 156 joints were scanned; 63 in the active group and 93 in the remission group. The most commonly scanned joints were MCP’s (50), PIP’s (50) and knees (29). Overall 57.7% of joints had significant US abnormalities: 74.6% in the active group, and 46.2% in the remission group (p=0.003). 64% of MCP joints had abnormal findings on US: 84.2% in the active group, and 51.6% in the remission group (p=0.053). 33.3% of ankle joints had abnormal findings: 62.5% in active group, and 0.0% in remission group (p=0.03). The calculated kappa coefficient of 0.68 indicates a high degree of inter-reader agreement. The most common abnormal finding was Power Doppler signal 47.4%. PIPs were the joints most commonly abnormal in the remission group. None of the patients in clinical remission who had normal ultrasound findings had elevated ESRs, but 42.1% of the patients with abnormal ultrasound findings had elevated ESRs (P = 0.5).

Table 1: Frequency of ultrasound abnormalities by group

All patients (N= 41)

Active (N=17)

Remission (N=24)

p-value

Odds Ratio

All joints

90/156 (57.7%)

47/63 (74.6%)

43/93 (46.2%)

0.003

3.51

(1.53, 8.04)

Elbow

3/4 (75.0%)

2/2 (100.0%)

1/2 (50.0%)

0.25

Wrist

4/6 (66.7%)

2/2 (100.0%)

2/4 (50.0%)

0.47

MCPs

32/50 (64.0%)

16/19 (84.2%)

16/31 (51.6%)

0.053

5.07

(0.98, 26.3)

PIPs

35/50 (70.0%)

16/19 (84.2%)

19/31 (61.3%)

0.12

3.66

(0.67, 19.9)

DIPs

1/2 (50.0%)

1/1 (100.0%)

0/1 (0.0%)

0.16

Knee

10/29 (34.5%)

5/12 (41.7%)

5/17 (29.4%)

0.53

1.81

(0.20, 16.3)

Ankle

5/15 (33.3%)

5/8 (62.5%)

0/7 (0.0%)

0.03

Conclusion: There were higher than expected findings of active synovitis (46%) in children believed to have been in clinical remission, with the most common active joints being the PIP, MCP, and ankle joints. Use of US with Power Doppler of these specific joints may prove to be helpful in assisting clinicians to more accurately define remission in children with JIA.


Disclosure: O. Kristinsson, None; L. Scalzi, None; M. Bruno, None; C. French, None; V. Chinchilli, None; B. Groh, None.

To cite this abstract in AMA style:

Kristinsson O, Scalzi L, Bruno M, French C, Chinchilli V, Groh B. Use of Ultrasound to Determine Remission Status in Children with Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 4). https://acrabstracts.org/abstract/use-of-ultrasound-to-determine-remission-status-in-children-with-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/use-of-ultrasound-to-determine-remission-status-in-children-with-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology